Natural Remedies shines at IPPE 2026, showcasing its science-backed phytogenics like NR-SBP. Their focus on sustainability, animal care, and productivity sets a new industry standard.
At IPPE 2026, Natural Remedies showcased its latest innovations in phytogenic solutions developed for monogastric species, highlighting how science-backed, plant-based formulations can support productivity, resilience, and responsible animal care. Th
.png "AstraZeneca to Invest $15B in China Through 2030 Expansion Plan")
AstraZeneca announced a $15 billion investment in China through 2030 to expand R&D, manufacturing, and advanced therapies, strengthening China-UK healthcare collaboration and delivering next-generation treatments worldwide.
Healthcare major Cupid Limited has secured CE certification for its HIV 1&2 and Hepatitis B test kits under EU IVDR, unlocking access to regulated European and global diagnostics markets.
RPG Life Sciences supports the India–EU FTA, highlighting the tariff reduction on pharmaceuticals. The move boosts India's pharma competitiveness, global exports, and access to affordable medicines.
Wockhardt’s Foviscu (WCK 4282) hits its Phase 3 endpoint, showing clinical cure rates comparable to meropenem for complicated UTIs, including ESBL infections, offering a vital alternative for antibiotic-resistant cases.
Roche has reported striking Phase II data for its CT-388 obesity drug, with patients achieving up to 22.5% weight loss over 48 weeks and strong metabolic improvements, supporting rapid advancement into Phase III trials.
.png "Eli Lilly Strikes $1.12B Gene Editing Deal With Seamless")
Eli Lilly has entered a deal worth up to $1.12 billion with gene-editing firm Seamless Therapeutics, signaling a major push into advanced genetic treatments for hearing loss and rare diseases.
Lubrizol will participate in WHX Dubai 2026, spotlighting its expanding medical device manufacturing capabilities and new investments in India, including a high-precision medical tubing facility in Chennai set to open mid-2026.
India’s India-EU FTA opens access to a $572.3 billion pharma and MedTech market, cutting tariffs and boosting exports, jobs, and manufacturing across key Indian states.
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")